ADMA BIOLOGICS INC
ADMANASDAQ🏆 #1781 by market capEarnings Nov 4US Equity
$9.92▲ $0.01 (+0.10%)
Live1h▼ 0.1%
24h▲ 0.1%
7d▲ 6.7%
14d▲ 14.0%
30d▲ 10.5%
1y▼ 40.8%
🏦Market Cap
$2.30B
Small Cap
📈Revenue Growth (YoY)
+8.0%
Slowing
📊Gross Margin
64.7%
High
💵FCF Margin
22.9%
Strong
⚖️P/S Ratio
4.3x
Fair
Otter Score
47
Weak
📊
Analyst Ratings
Price
$9.92
Total
10
Raised
0
Lowered
1
Avg PT
$18.67
H / L
$21 / $17
| Institution | Action | Rating | Date |
|---|---|---|---|
Mizuho | Reiterated | Outperform | 2026-07-15 |
Canaccord Genuity | Reiterated | Buy | 2026-05-07 |
Cantor Fitzgerald | Downgraded | Overweight → Neutral | 2026-03-26 |
Raymond James | Reiterated | Strong Buy | 2025-05-08 |
HC Wainwright & Co. | Reiterated | Buy | 2024-11-08 |
Oppenheimer | Reiterated | Outperform | 2020-05-07 |
H.C. Wainwright | Reiterated | Buy | 2020-03-16 |
Jefferies | Reiterated | Buy | 2019-06-04 |
Chardan Capital | Reiterated | Buy | 2018-07-30 |
Maxim Group | Reiterated | Buy | 2018-07-27 |
One row per institution, most recent rating